The influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy

scientific article published on 7 August 2012

The influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1933719112452472
P932PMC publication ID3676260
P698PubMed publication ID22872542

P50authorVinod K. MisraQ48777445
P2093author name stringPawan Kumar
Dawn P Misra
Vinod K Misra
Jennifer K Straughen
P2860cites workPotential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitroQ28115650
Obesity: preventing and managing the global epidemic. Report of a WHO consultationQ29547404
Leptin and the regulation of body weight in mammalsQ29615976
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesQ33918445
The effects of maternal weight gain patterns on term birth weight in African-American women.Q34092066
Placental development in normal and compromised pregnancies-- a reviewQ34615469
Angiogenesis modulates adipogenesis and obesityQ34677131
Adipose tissue dysfunction in obesityQ34974909
Possible role of placental leptin in pregnancy: a reviewQ35065095
The known and unknown of leptin in pregnancyQ36491152
The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm deliveryQ36784270
Preeclampsia and angiogenic imbalanceQ36971766
Adipokine dysregulation, adipose tissue inflammation and metabolic syndromeQ37580095
The perinatal implications of angiogenic factorsQ37649388
Leptin, the product of Ob gene, promotes angiogenesisQ38331380
Biological action of leptin as an angiogenic factorQ38333557
Leptin in human reproduction: serum leptin levels in pregnant and lactating womenQ38348913
Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancyQ43010300
Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies--role of leptin as a marker of pre-eclampsia: a prospective case-control studyQ44013669
Analysing the relationship between maternal weight gain and birthweight: exploration of four statistical issuesQ46140282
Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsiaQ46641283
Leptin and pre-eclampsia in black African parturientsQ46871289
Second trimester insulin resistance, early pregnancy body mass index and gestational weight gainQ47197128
Estimation of fetal weight with the use of head, body, and femur measurements--a prospective studyQ47228242
Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI.Q47387021
Leptin: a potential marker of placental insufficiencyQ47756816
Maternal morbid obesity and the risk of adverse pregnancy outcomeQ47861917
Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancyQ48020358
Pre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women.Q52217173
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humansQ73677617
Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancyQ73709712
Decreased maternal serum leptin in pregnancies complicated by preeclampsiaQ73835659
Increased leptin levels in preeclampsia: associations with BMI, estrogen and SHBG levelsQ80282940
Reduced plasma adiponectin and elevated leptin in pre-eclampsiaQ80514728
Human leptin induces angiogenesis in vivoQ81191687
Circulating leptin and angiogenic factors in preeclampsia patientsQ81306170
Serum leptin levels in preeclamptic pregnant women: relationship to thyroid-stimulating hormone, body mass index, and proteinuriaQ81663698
The influence of overweight and obesity on longitudinal trends in maternal serum leptin levels during pregnancyQ84774642
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectobesityQ12174
P304page(s)269-275
P577publication date2012-08-07
P1433published inReproductive SciencesQ7314305
P1476titleThe influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy
P478volume20

Reverse relations

cites work (P2860)
Q39034485Blood-based biomarkers of adverse perinatal outcomes in maternal obesity
Q37370379Body weight gain and serum leptin levels of non-overweight and overweight/obese pregnant women
Q37137270Changes in adipose tissue distribution during pregnancy in overweight and obese compared with normal weight women.
Q38307312Factors associated with prospective leptin concentrations throughout pregnancy in pregestational normal weight, overweight and obese women
Q57399095Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort
Q36422496Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms
Q39192889Maternal obesity and inflammatory mediators: A controversial association.
Q53683495Physical Activity and Risk of Preterm Birth in a Cohort of African American Women.
Q38881770Preterm Delivery as a Unique Pathophysiologic State Characterized by Maternal Soluble FMS-Like Tyrosine Kinase 1 and Uterine Artery Resistance During Pregnancy.

Search more.